Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer.
Gunn S, Reveles X, Weldon K, Barrera A, Ishaque M, Taylor D, McCaskill C, Kim J, Shah R, Mohammed M, Barry T, Kaiser B, Patnaik A, Tolcher A.
Gunn S, et al. Among authors: ishaque m.
J Ovarian Res. 2013 Jan 4;6(1):2. doi: 10.1186/1757-2215-6-2.
J Ovarian Res. 2013.
PMID: 23289505
Free PMC article.